Global Vaccine Safety

The latest version of the GVSI portfolio of activities available online

The latest GVSI portfolio of activities is now available. You will be able to glance through a number of new projects supported by various stakeholders that have recently join the effort. The latest tools and intelligence generated within the framework of the Initiative and offered to Member States to assist them in strengthening their vaccine pharmacovigilance systems include a template of AEFI notification form, an updated template of AEFI investigation form, the WHO vaccine reaction rates information sheets, a tool for assessing AEFI causality with its manual and aide-memoire, the newly launched Vaccine Pharmacovigilance Toolkit, a Brighton Collaboration Narcolepsy Case Definition etc.

The 5th Planning Group retreat of the Global Vaccine Safety Initiative

The fifth GVSI Planning Group retreat took place on 28-29 May 2014 in France aimed primarily at reviewing the portfolio of activities and to discuss the GVSI evaluation framework. The Initiative is at a turning point in strengthening the national pharmacovigilance systems with the first GVSI products successfully implemented and having reached the stage of evaluation of their impact.
The GVSI Planning Group has continued to provide overall direction for the Initiative. The next retreat is to be held in China in October this year along with the GVSI General Meeting and the meeting of the pharmacovigilance centres.

Focus on Africa 2014 – 2015: Workshop on Vaccine Safety and Pharmacovigilance for English-speaking countries

The three-day workshop organized in Accra, Ghana from 28-30 April 2014 helped eight Anglophone countries to map vaccine pharmacovigilance resources and develop work plans for strengthening AEFI surveillance. The workshop uniquely integrated 38 participants from national EPI, National Regulatory Authority, Pharmacovigilance centres, and WHO focal persons for EPI and Essential Medicines and Health Products from Ethiopia, Ghana, Kenya, Malawi, Nigeria, Tanzania, Uganda and Zimbabwe. The workshop enabled countries to ascertain key activities and resources available. This enabled prioritization, identifying focal persons, strategies and deadlines.

Focus on Africa 2014 – 2015: workshop on vaccine safety and pharmacovigilance

The three-day workshop organized in Grand Bassam, Ivory Coast, from 23 to 25 April 2014, gathered 37 representatives from EPI, National Regulatory Authorities, Pharmacovigilance centres, technical agencies and WHO EPI and Essential Medicines and Health Products focal persons from Ivory Coast, Burundi, Cameroon, Democratic Republic of Congo, Guinea, Madagascar and Togo. The aim was to map on going vaccine safety activities and existing resources and to update their Institutional Development Plan with a focus on vaccine pharmacovigilance. National work plans for strengthening vaccine pharmacovigilance were developed for the next two years and an implementation follow up framework agreed upon.

GVSI highlights